Atropine for prevention of cardiac dysrhythmias in patients with hepatocellular carcinoma undergoing percutaneous ethanol instillation: A randomized, placebo-controlled, double-blind trial

Liver International

Volumn 29, Issue 5, 2009, Pages 715-720

  Arnulf, Ferlitsch ^a   Monika, Schmid ^a   Herwig, Schmidinger ^a   Monika, Homoncik ^a   Johannes, Pleiner Duxneuner ^a   Gregor, Ulbrich ^a   Alfred, Gangl ^a   Markus, Peck Radosavljevic ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adverse event; Atropine; Bradyarrhythmia; Hepatocellular carcinoma; Percutaneous ethanol instillation

Indexed keywords

ALCOHOL; ATROPINE; PLACEBO;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART SINOATRIAL BLOCK; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LIVER CELL CARCINOMA; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR PREMATURE BEAT; TUMOR LOCALIZATION; TUMOR VOLUME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; ATROPINE; CARCINOMA, HEPATOCELLULAR; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 64749092295     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01905.x     Document Type: Article

References (25)

1. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18: 1121-6.
2. Lee MJ, Mueller PR, Dawson SL, et al. Percutaneous ethanol injection for the treatment of hepatic tumors: Indications, mechanism of action, technique, and efficacy. Am J Roentgenol 1995; 164: 215-20.
3. Livraghi T, Benedini V, Lazzaroni S, et al. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998; 83: 48-57.
4. Di Stasi M, Buscarini L, Livraghi T, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997; 32: 1168-73.
5. Sammak B, Yousef B, Abd El Bagi M, et al. Needle track seeding following percutaneous ethanol injection for treatment of hepatocellular carcinoma. Hepatogastroenterology 1998; 45: 1097-9.
6. Perrault J, McGill DB, Ott BJ, et al. Liver biopsy: Complications in 1000 in patients and outpatients. Gastroenterology 1978; 74: 103-106.
7. Ferlitsch A, Kreil A, Bauer E, et al. Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma. Eur J Clin Invest 2004; 34: 218-23.
8. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. Gut 1999; 45 (Suppl. 4): IV1-11.
9. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: Comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. Am J Roentgenol 2001; 177: 375-80.
10. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injectionfor small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-30.
11. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-99.
12. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-8.
13. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
14. Cayne NS, Faries PL, Trocciola SM, et al. Carotid angioplasty and stent-induced bradycardia and hypotension: Impact of prophylactic atropine administration and prior carotid endarterectomy. J Vasc Surg 2005; 41: 956-61.
15. Wright RA. Outpatient liver biopsy: One man's experience. South Med J 1991; 84: 889-90.
16. Villalta J, Estruch R, Antunez E, et al. Vagal neuropathy in chronic alcoholics: Relation to ethanol consumption. Alcohol Alcohol 1989; 24: 421-8.
17. Reed S, Porges S, Newlin D. Effect of alcohol on vagal regulation of cardiovascular function: Contributions of the polyvagal theory to the psychophysiology of alcohol. Exp Clin Psychopharmacol 1999; 7: 484-92.
18. Penna M, Brugere S, Canas M, et al. Cardiorespiratory reflex effects induced by intravenous administration of ethanol in rats. Alcohol 1985; 2: 603-9.
19. Tsutsui M, Matsuguchi T, Tsutsui H, et al. Alcohol-induced sinus bradycardia and hypotension in patients with syncope. Jpn Heart J 1992; 33: 875-9.
20. Tiniakos DG, Lee JA, Burt AD. Innervation of the liver: Morphology and function. Liver 1996; 16: 151-60.
21. Samonina G, Hakumaki M. Role of the parasympathetic nervous system in alcohol-induced bradycardia in conscious cats. Scand J Clin Lab Invest 1982; 42: 417-22.
22. Varga K, Gantenberg NS, Kunos G. Endogenous gamma-aminobutyric acid (GABA) mediates ethanol inhibition of vagally mediated reflex bradycardia elicited from aortic baroreceptors. J Pharmacol Exp Ther 1994; 268: 1057-62.
23. Kisella SM, Tuckey JP. Perioperative bradycardia and asystole: relationship to vasovagal syncope and the Bezold-Jarisch reflex. Br J Anesth 2001; 8: 859-68.
24. Rossinen J, Sinisalo J, Partanen J, et al. Effects of acute alcohol infusion on duration and dispersion of QT interval in male patients with coronary artery disease and in healthy controls. Clin Cardiol 1999; 22: 591-4.
25. Goodkind MJ, Gerber NH Jr, Mellen JR, et al. Altered intracardiac conduction after acute administration of ethanol in the dog. J Pharmacol Exp Ther 1975; 194: 633-8.